{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:55:47Z","timestamp":1766022947916,"version":"3.48.0"},"reference-count":50,"publisher":"e-Century Publishing Corporation","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/tvtb3045","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T04:02:40Z","timestamp":1743134560000},"page":"1604-1612","source":"Crossref","is-referenced-by-count":1,"title":["Advances in diagnosis and treatment of lymphoma-associated hemophagocytic syndrome"],"prefix":"10.62347","volume":"17","author":[{"given":"Fuli","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","unstructured":"Fan ZY and Tan H. Advances in diagnosis and treatment of lymphoma-associated hemophagocytic syndrome. Int J Blood Transfus Hematol 2020; 43: 405-412."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer&#xF3;n P, L&#xF3;pez-Guillermo A, Khamashta MA and Bosch X. Adult haemophagocytic syndrome. Lancet 2014; 383: 1503-1516.","journal-title":"Lancet"},{"key":"ref2","unstructured":"Lymphoma Professional Committee of the Chinese Anti-Cancer Association, Lymphocyte Disease Group of the Hematology Branch of the Chinese Medical Association, China Hemophagocytic Syndrome Expert Alliance. Expert consensus on diagnosis and treatment of lymphoma-associated hemophagocytic syndrome in China (2022 edition). Natl Med J China 2022; 102: 1794-1801."},{"key":"ref3","unstructured":"Zhang ZN, Hao YS and Zhao YQ. Hematology. Beijing: People&#x2019;s Medical Publishing House; 2019. pp. 679."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","unstructured":"Mosmann TR and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.","journal-title":"Immunol Today"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"4100","DOI":"10.1182\/blood.V89.11.4100","article-title":"Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis","volume":"89","author":"Osugi","year":"1997","unstructured":"Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S and Tawa A. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89: 4100-3.","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","article-title":"Hemophagocytic syndromes","volume":"21","author":"Janka","year":"2007","unstructured":"Janka GE. Hemophagocytic syndromes. Blood Rev 2007; 21: 245-53.","journal-title":"Blood Rev"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","unstructured":"Tang Y, Xu X, Song H, Yang S, Shi S, Wei J, Pan B, Zhao F, Liao C and Luo C. Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome. Br J Haematol 2008; 143: 84-91.","journal-title":"Br J Haematol"},{"key":"ref8","unstructured":"Hu F, Peng MJ, Zhan JY and Zhao Z. Advances in genetic alterations associated with chronic active Epstein-Barr virus infection. Infect Dis Info 2023; 36: 272-277."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2023.07.023","article-title":"Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants","volume":"153","author":"Bloch","year":"2024","unstructured":"Bloch C, Jais JP, Gil M, Boubaya M, Lepelletier Y, Bader-Meunier B, Mahlaoui N, Garcelon N, Lambotte O, Launay D, Larroche C, Lazaro E, Liffermann F, Lortholary O, Michel M, Michot JM, Morel P, Cheminant M, Suarez F, Terriou L, Urbanski G, Viallard JF, Alcais A, Fischer A, de Saint Basile G and Hermine O; French HLH Study Group. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants. J Allergy Clin Immunol 2024; 153: 256-264.","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.7754\/clin.lab.2023.230730","article-title":"Lamotrigine-Induced Hemophagocytic Lymphohistiocytosis with DRESS","volume":"70","author":"Wang","year":"2024","unstructured":"Wang H, Peng J, Zeng W and Pan X. Lamotrigine-Induced Hemophagocytic Lymphohistiocytosis with DRESS. Clin Lab 2024; 70: 138-41","journal-title":"Clin Lab"},{"key":"ref11","unstructured":"Pei DY and Wu W. Lamotrigine may induce hemophagocytic syndrome: a case report. J Clin Psychiatry 2023; 33: 315-317."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1182\/bloodadvances.2023011733","article-title":"Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T-and\/or NK-cell lymphoma","volume":"8","author":"Liu","year":"2024","unstructured":"Liu Y, Sardana R, Nemirovsky D, Frosina D, Jungbluth A, Johnson WT, Vardhana S, Arcila M, Horwitz SM, Derkach A, Dogan A and Xiao W. Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T-and\/or NK-cell lymphoma. Blood Adv 2024; 8: 3064-3075.","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ali K, Medina J and Benedetto PW. Severe lymphoma-associated hemophagocytic syndrome in a young woman. Cureus 2024; 16: e53649.","DOI":"10.7759\/cureus.53649"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/jcm13061643","article-title":"Diagnostic challenges in hemophagocytic lymphohistiocytosis, a rare, potentially fatal disease: two case studies","volume":"13","author":"Ionescu","year":"2024","unstructured":"Ionescu MD, Prajescu B, Taras R, Popescu N, Vidlescu R, Smarandoiu M, Rosca LE, Enculescu A, Berghea EC and Toma CL. Diagnostic challenges in hemophagocytic lymphohistiocytosis, a rare, potentially fatal disease: two case studies. J Clin Med 2024; 13: 1643.","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.mcna.2023.05.019","article-title":"Hemophagocytic lymphohistiocytosis in adolescents and young adults: genetic predisposition and secondary disease","volume":"108","author":"AE","year":"2024","unstructured":"Vasco AE, Talano JA and Broglie L. Hemophagocytic lymphohistiocytosis in adolescents and young adults: genetic predisposition and secondary disease. Med Clin North Am 2024; 108: 189-200.","journal-title":"Med Clin North Am"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Chalipat S, Kulkarni V, Malwade S, Shah P and Bijaspur P. Silvery gray hair syndrome with hemophagocytic lymphohistiocytosis: a case report. Cureus 2024; 16: e55649.","DOI":"10.7759\/cureus.55649"},{"key":"ref17","unstructured":"Muto G, Takahashi Y, Yamashita H and Mimori A. A case report of hemophagocytic syndrome with multiple cerebral infarction. Chin J Stroke 2022; 17: 539-543."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1442-200x.2000.01186.x","article-title":"Hemophagocytic lymphohistiocytosis with preceding neurologic signs and neutrophilia","volume":"42","author":"Yamamoto","year":"2000","unstructured":"Yamamoto K, Watanabe A, Kakihara T, Tanaka A and Uchiyama M. Hemophagocytic lymphohistiocytosis with preceding neurologic signs and neutrophilia. Pediatr Int 2000; 42: 167-169.","journal-title":"Pediatr Int"},{"key":"ref19","unstructured":"Deng XM, Mao SX, Yu YL, Qin N, Wang W and Cheng O. A case report of lymphoma-associated hemophagocytic syndrome with psychiatric symptoms as the initial symptom. J Apoplexy and Nervous Diseases 2016; 33: 1138-1139."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/MPH.0b013e3181f84a52","article-title":"Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010","volume":"33","author":"Imashuku","year":"2011","unstructured":"Imashuku S. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010. J Pediatr Hematol Oncol 2011; 33: 35-39.","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref21","unstructured":"Lymphoma Professional Committee of the Chinese Anti-Cancer Association. Expert consensus on diagnosis and treatment of lymphoma-associated hemophagocytic syndrome in China. Natl Med J China 2018; 98: 1389-1393."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"JI","year":"2007","unstructured":"Henter JI, Horne A, Aric&#xF3; M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J and Janka G. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-131.","journal-title":"Pediatr Blood Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P and Hejblum G. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 2014; 66: 2613-2620.","journal-title":"Arthritis Rheumatol"},{"key":"ref24","unstructured":"Takahashi N, Chubachi A, Miura I, Nakamura S and Miura A. Lymphoma-associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 1999; 40: 542-549."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/cancers15061839","article-title":"Diagnosis and management of adult malignancy-associated hemophagocytic lymphohistiocytosis","volume":"15","author":"Lee","year":"2023","unstructured":"Lee JC and Logan AC. Diagnosis and management of adult malignancy-associated hemophagocytic lymphohistiocytosis. Cancers (Basel) 2023; 15: 1839.","journal-title":"Cancers (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/cncr.30084","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes","volume":"122","author":"Tamamyan","year":"2016","unstructured":"Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang S, Abdelall W, Konoplev SN and Daver NG. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes. Cancer 2016; 122: 2857-2866.","journal-title":"Cancer"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Henter JI, Aric&#xF2; M, Egeler RM, Elinder G, Favara BE, Filipovich AH, Gadner H, Imashuku S, Janka-Schaub G, Komp D, Ladisch S and Webb D. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol 1997; 28: 342-347.","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.3.CO;2-Y"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","article-title":"Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis","volume":"126","author":"Wang","year":"2015","unstructured":"Wang Y, Huang W, Hu L, Cen X, Li L, Wang J, Shen J, Wei N and Wang Z. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 2015; 126: 2186-2192.","journal-title":"Blood"},{"key":"ref29","unstructured":"Wang Z and Wang JS. Diagnosis and treatment of malignancy-associated hemophagocytic lymphohistiocytosis. J Clin Hematol (China) 2023; 36: 1-4."},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Liang JH, Wang L, Zhu HY, Qian J, Liao H, Wu JZ, Xia Y, Wu W, Cao L, Fan L, Li JY and Xu W. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica 2020; 105: e29-e32.","DOI":"10.3324\/haematol.2019.220301"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"Ros&#xE9","year":"2019","unstructured":"La Ros&#xE9;e P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G and Henter JI. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019; 133: 2465-2477.","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the histiocyte society","volume":"6","author":"Ehl","year":"2018","unstructured":"Ehl S, Astigarraga I, von Bahr Greenwood T, Hines M, Horne A, Ishii E, Janka G, Jordan MB, La Ros&#xE9;e P, Lehmberg K, Machowicz R, Nichols KE, Sieni E, Wang Z and Henter JI. Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH steering committee of the histiocyte society. J Allergy Clin Immunol Pract 2018; 6: 1508-1517.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/pbc.21838","article-title":"Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis","volume":"52","author":"Thompson","year":"2009","unstructured":"Thompson PA, Allen CE, Horton T, Jones JY, Vinks AA and McClain KL. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2009; 52: 621-625.","journal-title":"Pediatr Blood Cancer"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1007\/s00432-020-03301-y","article-title":"Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome","volume":"146","author":"Zhou","year":"2020","unstructured":"Zhou L, Liu Y, Wen Z, Yang S, Li M, Zhu Q, Qiu S, Gao Y, Wang H, Yuan Y, Zhang H, Chen C, Zeng W, Guan Z and Pan X. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome. J Cancer Res Clin Oncol 2020; 146: 3063-3074.","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3324\/haematol.2023.283478","article-title":"Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis","volume":"109","author":"Ge","year":"2024","unstructured":"Ge J, Zhang Q, Ma H, Wang D, Zhao Y, Zhu T, Wang W, Zhou C, Wei A, Lian H, Qin M, Yang J, Li Z, Wang T and Zhang R. Ruxolitinib-based regimen in children with primary hemophagocytic lymphohistiocytosis. Haematologica 2024; 109: 458-465.","journal-title":"Haematologica"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","unstructured":"Vallurupalli M and Berliner N. Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood 2019; 134: 1783-1786.","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"22448","DOI":"10.1182\/bloodadvances.2023012217","article-title":"Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab","volume":"8","author":"Chandrakasan","year":"2024","unstructured":"Chandrakasan S, Jordan MB, Baker A, Behrens EM, Bhatla D, Chien M, Eckstein OS, Henry MM, Hermiston ML, Hinson AP, Leiding JW, Oladapo A, Patel SA, Pednekar P, Ray AK, D&#xE1;vila Salda&#xF1;a B, Sarangi SN, Walkovich KJ, Yee JD, Zoref-Lorenz A and Allen CE. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood Adv 2024; 8: 22448-2258.","journal-title":"Blood Adv"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Jordan MB and Locatelli F. Exposure-safety relationship for patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Pediatr Blood Cancer 2024; 71: e30778.","DOI":"10.1002\/pbc.30778"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","unstructured":"Marsh RA, Allen CE, McClain KL, Weinstein JL, Kanter J, Skiles J, Lee ND, Khan SP, Lawrence J, Mo JQ, Bleesing JJ, Filipovich AH and Jordan MB. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 2013; 60: 101-109.","journal-title":"Pediatr Blood Cancer"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0885066617711386","article-title":"Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically Ill adult patients with hemophagocytic lymphohistiocytosis","volume":"34","author":"Wohlfarth","year":"2019","unstructured":"Wohlfarth P, Agis H, Gualdoni GA, Weber J, Staudinger T, Schellongowski P and Robak O. Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically Ill adult patients with hemophagocytic lymphohistiocytosis. J Intensive Care Med 2019; 34: 723-731.","journal-title":"J Intensive Care Med"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","unstructured":"Schram AM and Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 2015; 125: 2908-2914.","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","volume":"38","author":"Knauft","year":"2024","unstructured":"Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Ros&#xE9;e P and Birndt S. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis. Leukemia 2024; 38: 235-249.","journal-title":"Leukemia"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","unstructured":"Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, Yamamoto K, Horiuchi H, Takada K, Ohshima K, Nakamura S, Kinukawa N, Oshimi K and Kawa K. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007; 86: 58-65.","journal-title":"Int J Hematol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood.2023020715","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival","volume":"143","author":"L&#xF6","year":"2024","unstructured":"L&#xF6;fstedt A, J&#xE4;dersten M, Meeths M and Henter JI. Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival. Blood 2024; 143: 233-242.","journal-title":"Blood"},{"key":"ref45","unstructured":"Wu K, Ma XB and Yang JR. Analysis of IL-6, IL-8 and IL-10 levels in adult patients with hemophagocytic syndrome and their correlation with prognosis. J Mod Lab Med 2023; 38: 19-22+124."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00277-023-05606-7","article-title":"A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin\/platelet ratio","volume":"103","author":"Feng","year":"2024","unstructured":"Feng C, Hua Z, He L, Yao S, Zou H, Zhu Y, Wang Z and Wang Y. A convenient and practical index for predicting the induction response in adult patients with hemophagocytic lymphohistiocytosis: ferritin\/platelet ratio. Ann Hematol 2024; 103: 715-723.","journal-title":"Ann Hematol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.transci.2018.10.001","article-title":"What&#x2019;s in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis","volume":"57","author":"Prokesch","year":"2018","unstructured":"Prokesch BC, Nagalla S, Ezzati F, Tujios SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster J, Martin AA, de la Morena MT and Wysocki CA. What&#x2019;s in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis. Transfus Apher Sci 2018; 57: 779-784.","journal-title":"Transfus Apher Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13023-020-01622-2","article-title":"The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis","volume":"15","author":"Yin","year":"2020","unstructured":"Yin G, Man C, Huang J, Liao S, Gao X, Tian T, Duan L, Xu J and Qiu H. The prognostic role of plasma fibrinogen in adult secondary hemophagocytic lymphohistiocytosis. Orphanet J Rare Dis 2020; 15: 332.","journal-title":"Orphanet J Rare Dis"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2169\/internalmedicine.48.1677","article-title":"Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome","volume":"48","author":"Okamoto","year":"2009","unstructured":"Okamoto M, Yamaguchi H, Isobe Y, Yokose N, Mizuki T, Tajika K, Gomi S, Hamaguchi H, Inokuchi K, Oshimi K and Dan K. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome. Intern Med 2009; 48: 775-81.","journal-title":"Intern Med"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0162515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:50:54Z","timestamp":1766022654000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/3\/ajtr0162515.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/tvtb3045","relation":{},"ISSN":["1943-8141"],"issn-type":[{"type":"electronic","value":"1943-8141"}],"subject":[],"published":{"date-parts":[[2025]]}}}